Ignite Creation Date:
2025-12-24 @ 3:56 PM
Ignite Modification Date:
2026-02-25 @ 8:48 PM
Study NCT ID:
NCT02775292
Status:
COMPLETED
Last Update Posted:
2025-07-30
First Post:
2016-05-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
15-001433
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None